Metabolic syndrome and prognostic factors in postmenopausal breast cancer patients

Breast J. 2019 May;25(3):548-551. doi: 10.1111/tbj.13280. Epub 2019 Apr 21.

Authors

Daniel María Lubián López¹, María Castillo Lara¹, Begoña Rodríguez Rodríguez¹, Carmen Aisha Butrón Hinojo¹, Antonia Martínez Herrera¹, Rafael Sánchez Borrego², Nicolás Mendoza Ladrón de Guevara³

Affiliations

¹ Department of Obstetrics and Gynecology, Faculty of Medicine, University Hospital of Puerto Real, Cádiz, Spain.
² Diatros Women's Care Clinic, Barcelona, Spain.
³ Faculty of Medicine, University of Granada, Granada, Spain.

PMID: 31006164
DOI: 10.1111/tbj.13280

No abstract available

MeSH terms

Breast Neoplasms / epidemiology
Breast Neoplasms / pathology*
Cross-Sectional Studies
Female
Humans
Metabolic Syndrome / blood
Metabolic Syndrome / complications*
Metabolic Syndrome / epidemiology
Middle Aged
Obesity / complications
Postmenopause
Prevalence
Prognosis
Receptors, Estrogen / metabolism

Substances

Receptors, Estrogen